Korean J Gastroenterol.  2019 Nov;74(5):267-273. 10.4166/kjg.2019.74.5.267.

New Potential Therapies for Chronic Hepatitis B

Affiliations
  • 1Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea. doctorkwon@catholic.ac.kr

Abstract

A HBV infection is a dynamic disease and long-term liver inflammation contributes to the development of liver cirrhosis and hepatocellular carcinoma. Currently available nucleos(t)ide analogues and pegylated interferon are effective in inhibiting HBV replication but rarely achieve HBsAg clearance. The present article introduces a new definition of HBV cure and several emerging therapies for HBV cure, including direct acting antivirals and immune modulatory antivirals.

Keyword

Hepatitis B virus; Therapeutics

MeSH Terms

Antiviral Agents
Carcinoma, Hepatocellular
Hepatitis B Surface Antigens
Hepatitis B virus
Hepatitis B, Chronic*
Hepatitis, Chronic*
Inflammation
Interferons
Liver
Liver Cirrhosis
Antiviral Agents
Hepatitis B Surface Antigens
Interferons
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr